20170406 Telix Logo.png
FDA Approves Phase II Kidney Cancer Therapy Study
September 13, 2021 18:41 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug...
Cancer Immunotherapy Documentary Wins Prestigious Golden Owl Award at Bergen International Film Festival
October 08, 2019 09:00 ET | Uncommon Productions
Boston, MA, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (“Uncommon”) is proud to announce that their latest documentary, Jim Allison: Breakthrough (“Breakthrough”) has received the 2019...
Rafael_Pharma-Logo+Slogan.png
UPDATED RELEASE: Rafael Pharmaceuticals Announces Initiation of Patient Enrollment for Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia
January 09, 2019 13:15 ET | Rafael Pharmaceutical Inc.
Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of patient...
20170406 Telix Logo.png
First Patient Imaged in Prostate Imaging Study
August 12, 2018 18:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
CipherHealth Celebrates the Work of Exceptional Nurses with Award
May 30, 2018 08:55 ET | CipherHealth
New York, New York, May 30, 2018 (GLOBE NEWSWIRE) -- CipherHealth, a leading healthcare patient engagement technology company, has recognized exceptional nurse or nursing teams across the country...
20170406 Telix Logo.png
Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration
December 13, 2017 17:30 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
Local Crush Cancer Event on May 7, Benefiting Cycle for Survival, Will Raise Funds for Rare Cancer Research
April 26, 2017 13:41 ET | Crush Cancer
VIRGINIA BEACH, Va., April 26, 2017 (GLOBE NEWSWIRE) -- Crush Cancer, benefiting Cycle for Survival, the movement to beat rare cancers, will host its third annual indoor cycling event Sunday, May...